Endoscopic palliation of malignant bile duct obstruction

Improvement in quality of life

Stuart Sherman, Glen Lehman, D. Earle, E. Lazaridis, J. Frakes, J. Johanson, T. Qaseem, D. Howell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Integration of measures of quality of life (QOL) with economic considerations is critical to define the optimal therapy for patients with malignant bile duct obstruction (MBDO). While endoscopic stenting is clearly indicated for relief of cholangitis or refractory pruritus, its role in patients with jaundice alone, abdominal pain, failure to thrive, etc., is less clear. We previously reported (GIE 1996;43:321A) that endoscopic stenting for MBDO was associated with significant improvements in physical well-being, emotional well-being, and functional well-being 30 days following stent placement. The aim of this study was to determine whether these results persist during long-term follow-up. METHODS: A modified Functional Assessment of Cancer Therapy (FACT) is the instrument used to assess QOL. This validated, self-administered questionnaire contains 43 items which are divided into the following 5 subscales: physical well-being, social/family well-being, relationship with doctor, emotional well-being, and functional well-being. An additional concerns category was added, addressing symptoms associated with MBDO. 110 patients with MBDO filled out the questionnaire prior to biliary stenting and 30 days following stent placement The subjects of this study are the 47 patients who were still alive and filled out the questionnaire 6 months after stent placement. The results at 6 months were compared to pre-stenting using paired T-tests. RESULTS: Endoscopic biliary stenting resulted in a statistically significant improvement in nausea (p=.018); meeting family needs (p=.03); feeling of well-being (p<.001); time spent in bed (p<.001); sex life (p=.03); nervousness (p<001); sadness (p=.001); coping with illness (p=.02); fear of dying (p=.004); ability to work (p<01); fulfillment from work (p=.005); enjoy life (p<.001); acceptance of illness (p=.005); sleep (p<.001); leisure pursuits (p<.001); quality of life (p=.001); weight (p=.006); digest food (p=.017); appetite (p=.005); jaundice (p=.003); and pruritus (p<.001). There are more than 10 times as many significant differences than would be expected by chance alone. SUMMARY: Endoscopic stenting for MBDO resulted in long-term improvements in physical well-being, social well-being, emotional well-being and functional well-being. CONCLUSIONS: 1) Endoscopic stenting for MBDO appears justifiable based on a significant long-term improvement in QOL An analysis of the economic considerations of such a recommendation is necessary. 2) Identification of subsets of patients unlikely to have an improved QOL (example: patients unlikely to live > 30 days) is necessary. In the era of economic constraint, these patients should not be considered appropriate candidates for stenting.

Original languageEnglish
JournalGastrointestinal Endoscopy
Volume45
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Cholestasis
Quality of Life
Stents
Economics
Failure to Thrive
Cholangitis
Pruritus
Jaundice
Nausea
Abdominal Pain
Emotions
Therapeutics
Surveys and Questionnaires
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Endoscopic palliation of malignant bile duct obstruction : Improvement in quality of life. / Sherman, Stuart; Lehman, Glen; Earle, D.; Lazaridis, E.; Frakes, J.; Johanson, J.; Qaseem, T.; Howell, D.

In: Gastrointestinal Endoscopy, Vol. 45, No. 4, 1997.

Research output: Contribution to journalArticle

Sherman, S, Lehman, G, Earle, D, Lazaridis, E, Frakes, J, Johanson, J, Qaseem, T & Howell, D 1997, 'Endoscopic palliation of malignant bile duct obstruction: Improvement in quality of life', Gastrointestinal Endoscopy, vol. 45, no. 4.
Sherman, Stuart ; Lehman, Glen ; Earle, D. ; Lazaridis, E. ; Frakes, J. ; Johanson, J. ; Qaseem, T. ; Howell, D. / Endoscopic palliation of malignant bile duct obstruction : Improvement in quality of life. In: Gastrointestinal Endoscopy. 1997 ; Vol. 45, No. 4.
@article{efef4e975bf0426bbdb8780e496c3541,
title = "Endoscopic palliation of malignant bile duct obstruction: Improvement in quality of life",
abstract = "Integration of measures of quality of life (QOL) with economic considerations is critical to define the optimal therapy for patients with malignant bile duct obstruction (MBDO). While endoscopic stenting is clearly indicated for relief of cholangitis or refractory pruritus, its role in patients with jaundice alone, abdominal pain, failure to thrive, etc., is less clear. We previously reported (GIE 1996;43:321A) that endoscopic stenting for MBDO was associated with significant improvements in physical well-being, emotional well-being, and functional well-being 30 days following stent placement. The aim of this study was to determine whether these results persist during long-term follow-up. METHODS: A modified Functional Assessment of Cancer Therapy (FACT) is the instrument used to assess QOL. This validated, self-administered questionnaire contains 43 items which are divided into the following 5 subscales: physical well-being, social/family well-being, relationship with doctor, emotional well-being, and functional well-being. An additional concerns category was added, addressing symptoms associated with MBDO. 110 patients with MBDO filled out the questionnaire prior to biliary stenting and 30 days following stent placement The subjects of this study are the 47 patients who were still alive and filled out the questionnaire 6 months after stent placement. The results at 6 months were compared to pre-stenting using paired T-tests. RESULTS: Endoscopic biliary stenting resulted in a statistically significant improvement in nausea (p=.018); meeting family needs (p=.03); feeling of well-being (p<.001); time spent in bed (p<.001); sex life (p=.03); nervousness (p<001); sadness (p=.001); coping with illness (p=.02); fear of dying (p=.004); ability to work (p<01); fulfillment from work (p=.005); enjoy life (p<.001); acceptance of illness (p=.005); sleep (p<.001); leisure pursuits (p<.001); quality of life (p=.001); weight (p=.006); digest food (p=.017); appetite (p=.005); jaundice (p=.003); and pruritus (p<.001). There are more than 10 times as many significant differences than would be expected by chance alone. SUMMARY: Endoscopic stenting for MBDO resulted in long-term improvements in physical well-being, social well-being, emotional well-being and functional well-being. CONCLUSIONS: 1) Endoscopic stenting for MBDO appears justifiable based on a significant long-term improvement in QOL An analysis of the economic considerations of such a recommendation is necessary. 2) Identification of subsets of patients unlikely to have an improved QOL (example: patients unlikely to live > 30 days) is necessary. In the era of economic constraint, these patients should not be considered appropriate candidates for stenting.",
author = "Stuart Sherman and Glen Lehman and D. Earle and E. Lazaridis and J. Frakes and J. Johanson and T. Qaseem and D. Howell",
year = "1997",
language = "English",
volume = "45",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Endoscopic palliation of malignant bile duct obstruction

T2 - Improvement in quality of life

AU - Sherman, Stuart

AU - Lehman, Glen

AU - Earle, D.

AU - Lazaridis, E.

AU - Frakes, J.

AU - Johanson, J.

AU - Qaseem, T.

AU - Howell, D.

PY - 1997

Y1 - 1997

N2 - Integration of measures of quality of life (QOL) with economic considerations is critical to define the optimal therapy for patients with malignant bile duct obstruction (MBDO). While endoscopic stenting is clearly indicated for relief of cholangitis or refractory pruritus, its role in patients with jaundice alone, abdominal pain, failure to thrive, etc., is less clear. We previously reported (GIE 1996;43:321A) that endoscopic stenting for MBDO was associated with significant improvements in physical well-being, emotional well-being, and functional well-being 30 days following stent placement. The aim of this study was to determine whether these results persist during long-term follow-up. METHODS: A modified Functional Assessment of Cancer Therapy (FACT) is the instrument used to assess QOL. This validated, self-administered questionnaire contains 43 items which are divided into the following 5 subscales: physical well-being, social/family well-being, relationship with doctor, emotional well-being, and functional well-being. An additional concerns category was added, addressing symptoms associated with MBDO. 110 patients with MBDO filled out the questionnaire prior to biliary stenting and 30 days following stent placement The subjects of this study are the 47 patients who were still alive and filled out the questionnaire 6 months after stent placement. The results at 6 months were compared to pre-stenting using paired T-tests. RESULTS: Endoscopic biliary stenting resulted in a statistically significant improvement in nausea (p=.018); meeting family needs (p=.03); feeling of well-being (p<.001); time spent in bed (p<.001); sex life (p=.03); nervousness (p<001); sadness (p=.001); coping with illness (p=.02); fear of dying (p=.004); ability to work (p<01); fulfillment from work (p=.005); enjoy life (p<.001); acceptance of illness (p=.005); sleep (p<.001); leisure pursuits (p<.001); quality of life (p=.001); weight (p=.006); digest food (p=.017); appetite (p=.005); jaundice (p=.003); and pruritus (p<.001). There are more than 10 times as many significant differences than would be expected by chance alone. SUMMARY: Endoscopic stenting for MBDO resulted in long-term improvements in physical well-being, social well-being, emotional well-being and functional well-being. CONCLUSIONS: 1) Endoscopic stenting for MBDO appears justifiable based on a significant long-term improvement in QOL An analysis of the economic considerations of such a recommendation is necessary. 2) Identification of subsets of patients unlikely to have an improved QOL (example: patients unlikely to live > 30 days) is necessary. In the era of economic constraint, these patients should not be considered appropriate candidates for stenting.

AB - Integration of measures of quality of life (QOL) with economic considerations is critical to define the optimal therapy for patients with malignant bile duct obstruction (MBDO). While endoscopic stenting is clearly indicated for relief of cholangitis or refractory pruritus, its role in patients with jaundice alone, abdominal pain, failure to thrive, etc., is less clear. We previously reported (GIE 1996;43:321A) that endoscopic stenting for MBDO was associated with significant improvements in physical well-being, emotional well-being, and functional well-being 30 days following stent placement. The aim of this study was to determine whether these results persist during long-term follow-up. METHODS: A modified Functional Assessment of Cancer Therapy (FACT) is the instrument used to assess QOL. This validated, self-administered questionnaire contains 43 items which are divided into the following 5 subscales: physical well-being, social/family well-being, relationship with doctor, emotional well-being, and functional well-being. An additional concerns category was added, addressing symptoms associated with MBDO. 110 patients with MBDO filled out the questionnaire prior to biliary stenting and 30 days following stent placement The subjects of this study are the 47 patients who were still alive and filled out the questionnaire 6 months after stent placement. The results at 6 months were compared to pre-stenting using paired T-tests. RESULTS: Endoscopic biliary stenting resulted in a statistically significant improvement in nausea (p=.018); meeting family needs (p=.03); feeling of well-being (p<.001); time spent in bed (p<.001); sex life (p=.03); nervousness (p<001); sadness (p=.001); coping with illness (p=.02); fear of dying (p=.004); ability to work (p<01); fulfillment from work (p=.005); enjoy life (p<.001); acceptance of illness (p=.005); sleep (p<.001); leisure pursuits (p<.001); quality of life (p=.001); weight (p=.006); digest food (p=.017); appetite (p=.005); jaundice (p=.003); and pruritus (p<.001). There are more than 10 times as many significant differences than would be expected by chance alone. SUMMARY: Endoscopic stenting for MBDO resulted in long-term improvements in physical well-being, social well-being, emotional well-being and functional well-being. CONCLUSIONS: 1) Endoscopic stenting for MBDO appears justifiable based on a significant long-term improvement in QOL An analysis of the economic considerations of such a recommendation is necessary. 2) Identification of subsets of patients unlikely to have an improved QOL (example: patients unlikely to live > 30 days) is necessary. In the era of economic constraint, these patients should not be considered appropriate candidates for stenting.

UR - http://www.scopus.com/inward/record.url?scp=0013334438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013334438&partnerID=8YFLogxK

M3 - Article

VL - 45

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -